Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$4.12 - $5.25 $74,572 - $95,025
-18,100 Closed
0 $0
Q3 2022

May 15, 2023

BUY
$4.42 - $5.43 $80,002 - $98,283
18,100 New
18,100 $81,000
Q3 2022

Nov 14, 2022

SELL
$4.42 - $5.43 $17,238 - $21,177
-3,900 Reduced 17.73%
18,100 $82,000
Q2 2022

Aug 15, 2022

SELL
$4.22 - $5.85 $31,835 - $44,132
-7,544 Reduced 25.53%
22,000 $99,000
Q1 2022

May 16, 2022

SELL
$5.43 - $6.81 $54,397 - $68,222
-10,018 Reduced 25.32%
29,544 $163,000
Q4 2021

Feb 15, 2022

BUY
$5.21 - $6.82 $18,558 - $24,292
3,562 Added 9.89%
39,562 $260,000
Q3 2021

Nov 15, 2021

BUY
$5.25 - $5.87 $131,250 - $146,750
25,000 Added 227.27%
36,000 $191,000
Q2 2021

Aug 16, 2021

BUY
$5.67 - $6.33 $62,370 - $69,630
11,000 New
11,000 $64,000

Others Institutions Holding KMDA

About KAMADA LTD


  • Ticker KMDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 44,800,500
  • Market Cap $246M
  • Description
  • Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...
More about KMDA
Track This Portfolio

Track Sg3 Management, LLC Portfolio

Follow Sg3 Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg3 Management, LLC with notifications on news.